Inecalcitol

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameInecalcitol
Drug Alias Name伊奈骨化醇Inecalcitolum依奈骨化醇SDB-112TX-522
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin D receptor agonists
TargetsVitamin D receptor
Therapy Area/IndicationsLeukemia, Myeloid, AcuteLeukemia, Myeloid, Chronic-Phase
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHybrigenics Corporation
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, AcuteLeukemia, Myeloid, Chronic-Phase

Other Information

ATC CodeN/A
Related LinksN/A